Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Sees Large Drop in Short Interest

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) saw a large decline in short interest in January. As of January 15th, there was short interest totaling 41,372 shares, a decline of 64.3% from the December 31st total of 115,921 shares. Based on an average daily volume of 21,596 shares, the short-interest ratio is presently 1.9 days. Based on an average daily volume of 21,596 shares, the short-interest ratio is presently 1.9 days.

Conduit Pharmaceuticals Price Performance

Shares of CDTTW opened at $0.01 on Wednesday. Conduit Pharmaceuticals has a 1 year low of $0.01 and a 1 year high of $0.02. The company has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01.

Conduit Pharmaceuticals Company Profile

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.